Genetic mutations in heart valve cells of the developing fetus lead to mitral valve prolapse, report a global collaborative of researchers. These mutations or genetic variations cause defects in ...

A cell-to-cell signaling network in mice that serves as a developmental timer that could provide a framework for better understanding the mechanisms underlying human heart valve disease, say ...

A global research collaborative including Medical University of South Carolina investigators report in today's Science Translational Medicine that defects in the primary cilia of the developing fetus ...

Mitral valve prolapse (MVP) is a common congenital abnormality of the heart that can cause severe complications such as arrhythmias, heart failure, and sudden cardiac death. To date, the causes of MVP ...

Defects in the primary cilia of the developing fetus can ultimately cause mitral valve prolapse later in life, reveals a new study. Defects in the primary cilia of the developing fetus could be the ...

WASHINGTON (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow ...

A pioneering heart valve replacement that grows at the same rate as the organ does could transform lives of children with defects, scientists say. The prosthetic could remove the need for patients to ...

"Creld1" is found to be the key gene for the development of heart valves in mice. This discovery is an important step forward in the molecular understanding of the pathogenesis of heart valve defects.

NOTE: A link to videos of the developing heart is at end of the release. The human heart confounds logic by starting to beat before it is fully formed —a developmental oddity shared by all vertebrate ...

WASHINGTON, March 30 (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year ...

WASHINGTON, March 30 (Reuters) - A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year ...

The US Food and Drug Administration (FDA) expanded approval of the Masters Series Heart Valve with Hemodynamic Plus (HP) Sewing Cuff (Abbott) to include the 15-mm valve size, making it the smallest ...